CSR Report and FY25: Dr. reddy's!

CSR Report Highlights for Dr. Reddy’s FY25:

• Strategic Focus: Dr. Reddy’s FY25 Business Responsibility and Sustainability Report (BRSR) demonstrates a strong commitment to the nine principles of the National Guidelines on Responsible Business Conduct (NGRBC), integrating environmental, social, and governance (ESG) objectives into its core business.

• Key CSR Areas:

  • Access to Medicines: Major focus on expanding access to affordable and innovative medicines globally, aiming to serve 1.5 billion patients by 2030. Initiatives include launching new drugs, expanding the product portfolio, and collaborating with organizations like Pharmazz, Junshi Biosciences, and Sanofi for novel therapies and vaccine distribution1.

  • Education & Skilling: Projects in education and livelihood enhancement, implemented through Dr. Reddy’s Foundation and partner NGOs, aim to promote education, skill development, and employability, especially for underprivileged communities.

  • Environmental Sustainability: Multiple projects with agencies like WWF-India and Wildlife Trust of India focus on environmental conservation and sustainability practices.

  • Governance: Enhanced ESG integration into board oversight, risk management, and executive compensation. The company conducted a double materiality assessment in FY25 to align with upcoming regulatory requirements and improve disclosure standards.

• Monitoring & Impact: All CSR projects are regularly monitored by the CSR team, with progress updates to the CSR Committee. Impact assessments are conducted as per the Companies Act, 2013, ensuring accountability and transparency in fund utilization.

Hot News (2025):

• Q1 FY25 Financial Results: Dr. Reddy’s reported Q1 FY25 revenues of ₹76,727 million, up 14% year-on-year, with a gross margin improvement to 60.4%. The company’s growth was primarily driven by its generics business, and it continues to invest in biologics and consumer healthcare.

• Sustainability Initiatives: The release of the FY25 BRSR and Integrated Annual Report highlights ongoing progress in sustainability, with independent assurance provided by DNV for the report’s core indicators.

• Women Safety Program: The SAP Progress Report for FY25 notes the impact of the Women Safety Ambassador Program, reaching over 1,800 stakeholders, reflecting Dr. Reddy’s focus on workplace safety and inclusion.

Summary Table: Key CSR Thematic Areas in FY25

Thematic Area	Key Initiatives/Partners	Focus Period
Access to Medicines	Pharmazz, Junshi Biosciences, Sanofi	Ongoing
Education & Skilling	Dr. Reddy’s Foundation, Naandi Foundation	Apr 2024–Mar 2025
Environmental Sustainability	WWF-India, Wildlife Trust of India	Apr 2024–Mar 2025
Women Safety & Inclusion	Women Safety Ambassador Program	FY25